Printout from Pearl Cohen Zedek Latzer Baratz


Dr. Craig Puckett is a Partner and leader of the Chemical Group section of the Life Sciences Group at Pearl Cohen's New York office. He has substantial experience counseling clients on developing their worldwide patent portfolio in order to achieve their business goals. Craig’s extensive experience includes counseling on freedom to operate, patentability, and invalidity opinions; ANDA paragraph IV certifications; due diligence analysis of patent portfolios; and patent procurement, both domestic and foreign. Craig’s domestic patent experience includes interviewing cases at the US Patent and Trademark Office (USPTO), drafting appeal briefs, and arguing cases before the Board of Patent Appeals and Interferences. His international patent procurement experience includes prosecuting patents in Europe, Germany, United Kingdom, Italy, Australia, China, Taiwan, Japan, Korea, Mexico, Peru, Argentina, and Chile.

Craig holds a doctoral degree in organic chemistry, and focuses his practice on  a variety of intellectual property law issues in the pharmaceutical and diversified chemical fields. His pharmaceutical experience extends to products from A to Z: generic versions of armodafinil, candesartan, leflunomide, ondasetron, and zolpidem, among many others. Craig has substantial expertise procuring patents directed to pharmaceutical compounds, medical formulations, methods of drug administration, methods of treating medical conditions, biotechnology (peptides and small molecules), medical devices, food chemistry, polymers, petroleum refinement, catalysts, and diversified chemicals. Craig has drafted over 150 domestic patent applications and over 60 opinions for his clients.

Prior to joining Pearl Cohen, Craig worked for the intellectual property boutiques of Pennie & Edmonds, LLP. and Kenyon & Kenyon LLP.  During his third year in law school, Craig served as a judicial intern with the Honorable Paul Michel of the Court of Appeals for the Federal Circuit.  Upon his return to law school, Craig was the Director of the Franklin Pierce Innovation Clinic, which counseled inventors and start-up companies in their patent portfolio development. 


  • New York State Bar
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. Court of Appeals for the Fourth Circuit
  • U.S. District Court, District of Columbia
  • U.S. District Court, Eastern District of Virginia
  • U.S. Patent & Trademark Office
  • Virginia State Bar


Franklin Pierce Law Center, J.D., 1998
University of Wisconsin-Madison, Ph.D. (Organic Chemistry), 1995
University of California - Los Angeles, B.Sc. (Chemistry), 1988


English & Spanish


Jantzi KL, Puckett CL, Guzei IA, Reich HJ. Solution structure and chelation properties of 2-thienyllithium reagents. J Org Chem. 2005 Sep 16;70(19):7520-9.

Reich HJ, Bevan MJ, Gudmundsson BO, Puckett CL. Are ATE complexes true intermediates in lithium-metalloid exchange? Subtle effects of ion-pair structure in lithium-tellurium and lithium-selenium exchange reactions. Angew Chem Int Ed Engl. 2002 Sep 16;41(18):3436-9.

Bonnesen PV, Puckett CL, Honeychuck RV, Hersh WH. Catalysis of Diels-Alder reactions by low oxidation state transition-metal Lewis acids: Fact and fiction. J Am Chem Soc. 1989;111(16):6070-81.